What mosquito diseases occur in the United States
Mosquito-borne diseases in the United States are primarily viral infections transmitted by species such as Aedes aegypti and Aedes albopictus (day-biting mosquitoes) and, in some regions, Culex mosquitoes. The most common domestically acquired mosquito-transmitted viruses include West Nile virus, followed by dengue, chikungunya, Zika virus, and eastern equine encephalitis (EEE). While most infections cause mild or no symptoms, a small proportion can lead to severe neuroinvasive disease. Understanding which diseases occur, where, and when helps guide targeted prevention and surveillance.
Key mosquito-borne diseases and their status in the US
Each mosquito-borne disease has distinct transmission patterns, geographic ranges, seasonal peaks, and public health impacts. The following table summarizes verified, high-information attributes for the most relevant mosquito-transmitted viruses affecting the United States.
| Pathogen | Disease profile in the US | Typical symptoms | Primary mosquito vectors | Peak transmission periods |
|---|---|---|---|---|
| West Nile virus | Most common mosquito-borne disease in the continental US; causes seasonal local outbreaks | Mostly asymptomatic; fever, headache, body aches; a small fraction develop neuroinvasive disease | Culex species | July–October, varies by region |
| Eastern equine encephalitis (EEE) | Rare but severe; cases reported in Atlantic and Gulf Coast states | Abrupt fever, headache, chills, vomiting; high risk of neuroinvasive illness | Culiseta melanura and bridge vectors | Late summer through fall in endemic areas |
| La Crosse encephalitis | Primary pediatric disease in the Upper Midwest and Mid-Atlantic states | Fever, headache, nausea, vomiting, fatigue; some neuroinvasive cases | Aedes triseriatus | Mid-summer into early fall |
| Dengue | Mostly travel-associated, but limited local transmission has occurred in Florida and Texas | High fever, severe headache, rash, joint and muscle pain; severe dengue is uncommon in the US | Aedes aegypti and Ae. albopictus | Warm months, with potential year-time transmission in southern regions |
| Chikungunya | Mostly imported; rare local outbreaks in Florida and Texas | Sudden fever and severe joint pain, which can persist for weeks or months | Aedes aegypti and Ae. albopictus | Warm months; no seasonal peak in southern locations with year-round mosquitoes |
| Zika virus | Very few locally acquired cases since 2016; mainly travel-associated now | Often mild; fever, rash, joint pain, conjunctivitis; important concern in pregnancy | Aedes aegypti and Ae. albopictus | Warm months; no ongoing widespread local transmission |
West Nile virus
West Nile virus is the leading cause of mosquito-borne disease reports in the continental United States. It is maintained in a mosquito-bird cycle, with Culex mosquitoes serving as primary vectors. Most people infected remain asymptomatic. When illness occurs, symptoms range from acute febrile illness to meningitis or encephalitis, particularly in older adults and people with weakened immune systems. Surveillance focuses on human cases, mosquito pools, and bird serology to guide control measures.
Eastern equine encephalitis (EEE)
EEE is rare but among the most severe mosquito-borne diseases in the US. The virus cycles between Culiseta melanura mosquitoes in hardwood swamps and avian hosts. Occasional spillover occurs into humans and other mammals via bridge vectors. Recent years have seen cases clustered in the Atlantic and Gulf coastal states, with high case-fatality rates and substantial neurologic sequelosis among survivors. Public health responses include mosquito surveillance, source reduction in woodland habitats, and public messaging during peak seasons.
La Crosse encephalitis
La Crosse virus is the leading cause of mosquito-borne encephalitis in US children, primarily in the Upper Midwest and Mid-Atlantic regions. The mosquito vector, Aedes triseriatus, breeds in tree holes and artificial containers. Illness typically presents in summer with fever, headache, and neuroinvasive disease in a subset of pediatric cases. Prevention emphasizes reducing container habitats near homes and daycare settings where children are present.
Where mosquito disease risk is highest in the United States
Risk varies by pathogen, mosquito ecology, climate, and human exposure patterns. In general, local transmission of dengue, chikungunya, and Zika is most likely in the Gulf Coast states and southern parts of the Southwest where Aedes aegypti is established and where travelers can introduce the viruses. EEE risk is elevated in hardwood swamps along the Atlantic and Gulf Coasts during late summer and fall. West Nile virus activity is widespread, with regular summertime and early-fall increases in both urban and suburban areas. La Crosse encephalitis risk is highest in wooded, humid regions of the Upper Midwest and Mid-Atlantic during mid to late summer.
Recognizing symptoms and when to seek care
Symptoms of mosquito-borne disease range from nonspecific febrile illness to severe neurologic disease. Common early signs include sudden fever, headache, body aches, joint pain, rash, and fatigue. Neuroinvasive signs—such as high fever with severe headache, neck stiffness, confusion, seizures, or weakness—require immediate medical attention. Because symptoms overlap with many other illnesses, clinicians should consider mosquito-borne disease in patients with compatible symptoms and relevant exposure or travel history, particularly during peak transmission months.
Science-based prevention strategies
Preventing mosquito bites is the most effective way to reduce disease risk. In areas with local transmission or during periods of high mosquito activity, public health authorities recommend a combination of personal and community-level measures. These include using EPA-registered insect repellents, wearing long sleeves and pants, installing or repairing window and door screens, emptying standing water containers, supporting local mosquito surveillance, and, where applicable, supporting targeted insecticide applications guided by public health officials. Travelers should review destination-specific risks and enhance protection accordingly.
Interpreting surveillance and outbreak information
Annual mosquito and arbovirus surveillance programs track mosquito abundance, infection rates in mosquito pools, and human case counts. These datasets support timely warnings and control decisions. It is important to interpret single-case reports in context, because high mosquito infection rates or small clusters can precede larger human outbreaks, while high human case counts may reflect prior enzootic transmission. Seasonal patterns help the public and clinicians anticipate periods of heightened risk and prioritize preventive behaviors throughout the mosquito season.